| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |